L. Grote (Göteborg, Sweden), S. Schiza (Heraklion, Greece)
Late Breaking Abstract - Does adaptive servo ventilation lead to hypocapnia? A. Barleben (Schwerin, Germany), W. Grüning (Schwerin, Germany)
| |
BLOCKAGE OF TLR4 OR NLRP3 INHIBITS IL-1ß ACTIVATION IN RESPONSE TO INTERMITTENT HYPOXIA S. Fitzpatrick (Dublin, Ireland), A. King (Dublin, Ireland), S. Ryan (Dublin, Ireland)
| |
Intranasal leptin prevents opioid-induced respiratory depression C. Freire (Baltimore, United States of America), H. Pho (Baltimore, United States of America), L. Kim (Baltimore, United States of America), X. Wang (Washington, United States of America), J. Dyavanapalli (Washington, United States of America), S. Streeter (Baltimore, United States of America), T. Fleury-Curado (Baltimore, United States of America), D. Mendelowitz (Baltimore, United States of America), V. Polotsky (Baltimore, United States of America)
| |
The effect of CPAP on quality of life in patients with ‘very’ mild Obstructive Sleep Apnoea (OSA): Results from a subset of the MERGE Randomised Trial J. Kelly (London, United Kingdom), A. Wimms (Sydney, Australia), C. Turnbull (Oxford, United Kingdom), A. Mcmillan (Stevenage, United Kingdom), S. Craig (Liverpool, United Kingdom), J. O'Reilly (Liverpool, United Kingdom), A. Nickol (Oxford, United Kingdom), E. Hedley (Oxford, United Kingdom), M. Decker (Encinita, United States of America), L. Willes (Encinita, United States of America), P. Calverley (Liverpool, United Kingdom), A. Benjafield (Sydney, Australia), J. Stradling (Oxford, United Kingdom), M. Morrell (London, United Kingdom)
| |
FACE: Phenotyping analysis of chronic heart failure (CHF) patients with sleep disordered breathing (SDB) indicated for adaptive servoventilation (ASV): 2-year follow-up results. R. Tamisier (Grenoble, France), T. Damy (Creteil, France), J. Davy (Montpellier, France), J. Verbraecken (Antwerp, Belgium), S. Bailly (Grenoble, France), F. Lavergne (Saint-Priest, France), A. Palot (Marseille, France), F. Goutorbe (Beziers, France), J. Pepin (Grenoble, France), M. D'Ortho (Paris, France)
| |
Effects of CPAP and mandibular advancement devices on cardiac biomarkers in patients with obstructive sleep apnea I. Andreieva (Zaporizhzhia, Ukraine)
| |
Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial R. Tamisier (Grenoble, France), E. Treptow (Grenoble, France), M. Joyeux-Faure (Grenoble, France), P. Lévy (Grenoble, France), M. Sapène (Bordeaux, France), M. Benmerad (Grenoble, France), S. Bailly (Grenoble, France), Y. Grillet (Valence, France), B. Stach (Valencienne, France), J. Muir (Bois Guillaume, France), H. Pegliasco (Marseille, France), J. Pépin (Grenoble, France)
| |
Effect of CPAP treatment on adhesion molecules in coronary artery disease with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial D. Zou (Gothenburg, Sweden), Y. Celik (Istanbul, Turkey), T. Lindberg (Stockholm, Sweden), E. Thunström (Gothenburg, Sweden), Y. Peker (Istanbul, Turkey)
| |